Страна: Армения
Язык: английский
Источник: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում
ibuprofen
FAMAR A.V.E. ANTHOUSSA PLANT
M01AE01
ibuprofen
800mg
tablets film-coated prolonged-release
20(2x10) in blister
Prescription
Registered
2021-03-18
Brufen Retard - Summary of Product Characteristics (SmPC) Page 1 of 8 Summary of Product Characteristics 1. NAME OF THE MEDICINAL PRODUCT Brufen Retard 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Active Ingredient: Ibuprofen – 800 mg For a full list of excipients see section 6.1. 3. PHARMACEUTICAL FORM Prolonged-release film-coated tablets. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Brufen Retard is indicated for its analgesic and anti-inflammatory effects in the treatment of rheumatoid arthritis (including juvenile rheumatoid arthritis or Still's disease), ankylosing spondylitis, osteoarthritis and other non- rheumatoid (seronegative) arthropathies. In the treatment of non-articular rheumatic conditions, Brufen Retard is indicated in periarticular conditions such as frozen shoulder (capsulitis), bursitis, tendinitis, tenosynovitis and low back pain; Brufen Retard can also be used in soft-tissue injuries such as sprains and strains. Brufen Retard is also indicated for its analgesic effect in the relief of mild to moderate pain such as dysmenorrhoea, dental and post-operative pain and for symptomatic relief of headache including migraine headache. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Undesirable effects may be minimised by using the lowest effective dose for the shortest duration necessary to control symptoms (see section 4.4). Adults and children over 12 years of age: Two tablets taken as a single daily dose, preferably in the early evening well before retiring to bed. The tablets should be swallowed whole with plenty of fluid and not chewed, broken, crushed or sucked on to avoid oral discomfort and throat irritation. In severe or acute conditions, total daily dosage may be increased to three tablets in two divided doses. Children: Not recommended for children under 12 years. Elderly: The elderly are at increased risk of serious consequences of adverse reactions. If an NSAID is considered necessary, the lowest effective dose should be used and for the shortest possible duration. The patient should Прочитать полный документ